Choroidal thickening and temporal RNFL thinning in TRD patients: no structural retinal changes following TMS treatment
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.119430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Beyazit Garip und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Gülhane Training and Research Hospital, Gn.Tevfik Saglam Cad. Etlik, Ankara, Türkiye. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Treatment-resistant depression (TRD) is a particularly challenging subset of major depressive disorder (MDD), often unresponsive to conventional antidepressants. Transcranial magnetic stimulation (TMS) is recognized as an effective and reliable alternative treatment for patients with TRD. However, the effects of long-term functional changes induced by TMS treatment on retinal structures remain unclear. In this prospective study, a total of 32 patients with TRD were evaluated for retinal nerve fiber layer (RNFL), macula and choroidal thickness changes before and after TMS treatment. Patients received either intermittent theta burst stimulation (iTBS) or repetitive TMS (rTMS) targeting the left dorsolateral prefrontal cortex. The protocol consisted of five days a week, with a total of 20 daily sessions over four weeks. Retinal measurements, including central macula thickness, RNFL, and choroidal thickness, were conducted using Spectral Domain Optical Coherence Tomography (SD-OCT) and enhanced depth imaging (EDI) mode. TRD patients had thicker choroids in both eyes and reduced left eye temporal RNFL thickness compared to healthy controls (p values 0.05). TRD patients exhibited significant changes in choroid and RNFL thickness, as measured by OCT imaging. TMS treatment did not result in significant alterations in these retinal measurements overall, but some retinal measurements may be affected under specific conditions such as gender, antidepressant drug type, and additional drug use. Further research focusing on these subgroups is necessary to better understand the effects of TMS on retinal structures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Gülhane Training and Research Hospital, Gn.Tevfik Saglam Cad. Etlik, Ankara, Türkiye.
- Department of Ophthalmology, University of Health Sciences, Gülhane School of Medicine, Gn.Tevfik Saglam Cad. Etlik, Ankara, Türkiye.
- Department of Anatomy and Cell Biology, University of Western Ontario, 1151 Richmond St, London, ON N6A 3K7, Canada. Electronic address: hkayir@uwo.ca.
Zitieren
APA
Garip, B., Demir, S., Kucukevcilioglu, M., & Kayir, H. (2025). Choroidal thickening and temporal RNFL thinning in TRD patients: no structural retinal changes following TMS treatment. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119430
Vancouver
Garip B, Demir S, Kucukevcilioglu M, Kayir H. Choroidal thickening and temporal RNFL thinning in TRD patients: no structural retinal changes following TMS treatment. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119430
BibTeX
@article{Garip2025,
author = {Garip, Beyazit and Demir, Suleyman and Kucukevcilioglu, Murat and Kayir, Hakan},
title = {Choroidal thickening and temporal RNFL thinning in TRD patients: no structural retinal changes following TMS treatment},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.119430}
}
EUVIMED